Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 136, Issue 5, Pages E326-E339
Publisher
Wiley
Online
2014-09-18
DOI
10.1002/ijc.29222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endothelial Cell-Secreted EGF Induces Epithelial to Mesenchymal Transition and Endows Head and Neck Cancer Cells with Stem-like Phenotype
- (2014) Z. Zhang et al. CANCER RESEARCH
- Lack of CD24 expression in mice reduces the number of leukocytes in the colon
- (2014) Niko P. Bretz et al. IMMUNOLOGY LETTERS
- Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
- (2014) J Diessner et al. Cell Death & Disease
- L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
- (2013) Alain G. Zeimet et al. JNCI-Journal of the National Cancer Institute
- Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation
- (2012) S. Bondong et al. ANNALS OF ONCOLOGY
- Hypoxia Activated EGFR Signaling Induces Epithelial to Mesenchymal Transition (EMT)
- (2012) Ashish Misra et al. PLoS One
- Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma
- (2011) Heiner Schäfer et al. CANCER LETTERS
- Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent
- (2011) Heiner Schäfer et al. CARCINOGENESIS
- L1-CAM-targeted antibody therapy and 177Lu-radioimmunotherapy of disseminated ovarian cancer
- (2011) Eliane Fischer et al. INTERNATIONAL JOURNAL OF CANCER
- Positive Expression of L1-CAM is Associated with Perineural Invasion and Poor Outcome in Pancreatic Ductal Adenocarcinoma
- (2010) Qi-Wen Ben et al. ANNALS OF SURGICAL ONCOLOGY
- The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
- (2010) SaeGwang Park et al. CANCER CELL
- Therapeutic Antibodies to Human L1CAM: Functional Characterization and Application in a Mouse Model for Ovarian Carcinoma
- (2010) S. Wolterink et al. CANCER RESEARCH
- L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells
- (2010) K. Doberstein et al. CARCINOGENESIS
- L1CAM malfunction in the nervous system and human carcinomas
- (2010) Michael K. E. Schäfer et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- L1CAM–integrin interaction induces constitutive NF-κB activation in pancreatic adenocarcinoma cells by enhancing IL-1β expression
- (2010) H Kiefel et al. ONCOGENE
- Improving the species cross-reactivity of an antibody using computational design
- (2009) Christopher J. Farady et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor 1- and Slug-Dependent: Role in Malignant Transformation of Pancreatic Cancer
- (2009) C. Geismann et al. CANCER RESEARCH
- Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas
- (2009) Monica Huszar et al. JOURNAL OF PATHOLOGY
- The RGD integrin binding site in human L1-CAM is important for nuclear signaling
- (2008) D GAST et al. EXPERIMENTAL CELL RESEARCH
- Epithelial–mesenchymal transition and the invasive potential of tumors
- (2008) Nancy Gavert et al. TRENDS IN MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started